Enanta Pharmaceuticals, Inc lost $3.84 per diluted share in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Enanta Pharmaceuticals, Inc has filed alongside them.
FY2025 annual
EPS (Diluted)-$3.84
YoYn/m
5Y CAGRn/m
Source SEC Filings (10-K/10-Q)Latest period Q3 FY2026, ended Jun 30, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
ENTA EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Enanta Pharmaceuticals, Inc's diluted earnings per share in fiscal year 2025?
Enanta Pharmaceuticals, Inc lost $3.84 per diluted share in fiscal year 2025.
How fast is Enanta Pharmaceuticals, Inc's diluted earnings per share growing?
Enanta Pharmaceuticals, Inc (ENTA) reported a loss of $5.48 per diluted share in fiscal year 2024 and a loss of $3.84 per diluted share in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
How has Enanta Pharmaceuticals, Inc's diluted earnings per share changed over the years?
Across the 15 fiscal years this page covers, Enanta Pharmaceuticals, Inc (ENTA) diluted earnings per share went from $1.32 in fiscal year 2011 to -$3.84 in fiscal year 2025.
What was Enanta Pharmaceuticals, Inc's diluted earnings per share in the most recent quarter?
Enanta Pharmaceuticals, Inc (ENTA) reported -$0.67 in diluted earnings per share in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Enanta Pharmaceuticals, Inc (ENTA) reported on that line in every period on record.
